Medicine Is Making
Real Progress

Discovery of a rare genetic mutation leads to HIV cure in a patient, offering hope for future treatments.

UT MD Anderson shares exciting new cancer research breakthroughs at major conference.

A breakthrough transseptal puncture device receives FDA clearance, offering patients a safer alternative for cardiac procedures.

New research identifies potential treatment pathway for rare Rett Syndrome, offering hope where none existed before.

Revolution Medicines' late-stage trial success brings potential breakthrough pancreatic cancer treatment closer to patients.

Groundbreaking porcine kidney transplant trial offers hope for patients awaiting organ transplants.

Multiple new oncology drugs received FDA approval, expanding treatment options for cancer patients.

FDA approves new cancer drug for trials using innovative nonanimal data, marking progress in both treatment and ethical research.

Groundbreaking microRNA research may unlock new treatments for stress-related conditions.

A cancer treatment demonstrates unexpected benefits beyond initial scientific predictions.

Researchers discover a drug that can draw dormant HIV out of immune cells, offering potential for improved treatment strategies.

CorTec's brain-computer interface receives FDA breakthrough designation to help stroke patients regain mobility and independence.

Event encourages rural youth to pursue medical careers and improve healthcare access.

AI breakthroughs by major biotech and tech companies are accelerating drug discovery and surgical innovation, advancing treatment options.

UNC pharmacy researchers are making progress toward breakthrough treatments for pediatric brain cancer.

Researchers have achieved promising results with a potential new treatment for the deadly brain cancer glioblastoma.

A new daily pill shows promise in extending dogs' lifespans, offering hope for pet owners.

CAR T-Cell cancer therapy shows potential to treat autoimmune diseases, opening new therapeutic possibilities.

FDA clears testing of innovative CAR-T therapy for autoimmune diseases, opening new therapeutic possibilities.

Teddy Bear Clinic gives children hands-on medical experience, reducing healthcare anxiety through play.

Educational museum exhibit promotes healthy eating habits and farm-to-table learning for children.

A symposium showcases significant progress in gastrointestinal cancer treatment options and research initiatives.

UVA scientists develop AI tools that accelerate the discovery of new drugs, bringing potential treatments to patients faster.

A medical breakthrough helps a patient make remarkable progress in their Parkinson's disease recovery.

Breakthrough biomarker discovery approach combines genomic and phenotypic evidence to better understand and treat PTSD.

International trial launches to develop better cancer treatments specifically for young people.

A breakthrough treatment offers renewed hope for Parkinson's patients after years of challenging disease progression.

Seven FDA-approved neurological treatments in early 2026 provide neurologists with powerful new therapeutic options.

VAI researchers are making meaningful progress toward treatments and a potential cure for Parkinson's disease.

A new model is improving the efficiency and effectiveness of medical discovery processes.

Synthetic data is accelerating medical discovery while preserving patient privacy and trust.

Researchers are making significant progress toward developing treatments and a potential cure for Parkinson's disease.

Dual treatment breakthrough addresses both lung cancer and muscle loss, improving quality of life for patients.

New VA law prepares to implement FDA-approved psychedelic treatments for veterans.

Research into cancer prevention breakthroughs could transform outcomes by stopping cancer before it develops.

New discovery in eye cancer treatment offers patients additional therapeutic options.

FDA approval of a new oral GLP-1 pill offers patients another accessible weight loss treatment.

Eli Lilly's new weight-loss pill receives FDA approval, offering patients an additional therapeutic option for obesity management.

A newly FDA-approved drug gives hope to families racing to save their children's lives from serious illness.

FDA approval of Eli Lilly's GLP-1 pill provides patients with a new oral option for effective weight loss treatment.

A strategic partnership between ABK Biomedical and MURR aims to advance a groundbreaking cancer therapy toward clinical use.

FibroBiologics successfully manufactures a promising drug candidate to treat diabetic foot ulcers.

Identification of pancreatic cancer's vulnerability opens promising new avenues for developing more effective treatments.

FDA accepts priority review of new drug for rare developmental epilepsy, offering hope to affected families.

Free AI drug discovery platform launched to accelerate development of treatments for global diseases.

Eli Lilly's $2.75 billion investment in AI-driven drug discovery promises to accelerate development of innovative treatments.

A fundraiser raised $3.5M to support breakthrough cancer research that could transform patient outcomes.

NTU team reports promising cancer research breakthrough spanning early detection to targeted therapy.

FDA made impactful decisions in neurology that advance patient treatment options.

Major biotech partnership expands AI-powered drug discovery capabilities for faster medication development.

Memorial Sloan Kettering's new colorectal cancer treatments aim to significantly reduce mortality rates in the coming years.

Mavacamten significantly reduces heart obstruction in teenagers with hypertrophic cardiomyopathy, offering new hope for young patients with this serious condition.

FDA's removal of dual-study requirement expedites drug approvals and speeds life-saving treatments to patients.

Emerging treatments and potential cures for HIV and cancer are on the horizon.

An experimental weight loss drug shows transformative potential for patients seeking new treatment options.

Innovative CAR-T cell therapy receives FDA Breakthrough Therapy designation, offering new hope for patients.

A historic Swiss medical breakthrough eliminated cretinism in the Alps, transforming countless lives.

Latest ALS research and clinical trials show promising developments in understanding and treating this challenging disease.

Analysis of clinical trial success rates in the 21st century provides insights for improving drug development and approval processes.